Department of General Practice, University of Turku and Turku University Hospital, Turku, Finland; Pihlajalinna Plc, Finland.
Folkhälsan Research Center, Helsinki, Finland; Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland.
Prim Care Diabetes. 2024 Oct;18(5):493-500. doi: 10.1016/j.pcd.2024.08.004. Epub 2024 Sep 2.
To compare 13-year mortality rates in normoglycemic, prediabetic and diabetic subjects attending a community-based screening and intervention programme.
Population survey identified 2569 cardiovascular disease (CVD) white risk subjects aged 45-70 years and without manifested CVD or diabetes. Oral glucose tolerance test was performed, and multifactorial intervention was provided. Effect of glycemic status on mortality was estimated in models adjusted for age, gender, education years, smoking, body mass index, mean arterial pressure, total cholesterol, and physical activity.
Of the subjects, 2055 (77 %) were normoglycemic, 380 (14 %) had prediabetes and 224 (9 %) diabetes. Compared to the normoglycemic group, the fully adjusted hazard ratios (HR) for all-cause mortality were 1.34 (95 % CI: 0.98-1.83) in the prediabetes group and 2.31 (95 % CI: 1.62-3.31) in the diabetes group. Standardized mortality rates were 0.63 (95 % CI: 0.54-0.73), 0.91 (95 % CI: 0.69-1.18), and 1.55 (95 % CI: 1.19-2.02) in the normoglycemic, prediabetes, and diabetes groups, respectively. The most common cause of death was cancer (42 % of all deaths), followed by CVD (28 %).
CONCLUSIONS/INTERPRETATION: Screen-detected diabetes carries a substantial risk of death even after primary care intervention. The pattern of excess mortality has shifted towards cancer deaths.
比较参加社区筛查和干预计划的血糖正常、糖尿病前期和糖尿病患者的 13 年死亡率。
人群调查确定了 2569 名年龄在 45-70 岁之间、无心血管疾病(CVD)或糖尿病的心血管疾病(CVD)白人高危人群。进行口服葡萄糖耐量试验,并提供多因素干预。在调整年龄、性别、受教育年限、吸烟、体重指数、平均动脉压、总胆固醇和体力活动的模型中,估计血糖状态对死亡率的影响。
在这些受试者中,2055 名(77%)血糖正常,380 名(14%)有糖尿病前期,224 名(9%)患有糖尿病。与血糖正常组相比,糖尿病前期组全因死亡率的校正后危险比(HR)为 1.34(95%可信区间:0.98-1.83),糖尿病组为 2.31(95%可信区间:1.62-3.31)。标准化死亡率分别为血糖正常组 0.63(95%可信区间:0.54-0.73)、糖尿病前期组 0.91(95%可信区间:0.69-1.18)和糖尿病组 1.55(95%可信区间:1.19-2.02)。最常见的死亡原因是癌症(所有死亡的 42%),其次是心血管疾病(28%)。
结论/解释:即使在初级保健干预后,筛查发现的糖尿病也会带来实质性的死亡风险。死亡的超额模式已转向癌症死亡。